Source: Zacks

Accelerate: Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System

AXDX's Arc system gains FDA clearance, automating blood culture prep for faster microbial ID, improved sepsis outcomes and reduced hospital costs.

Read full article »
Annual Revenue
$5.0-25M
Employees
100-250
Jack Phillips's photo - CEO of Accelerate

CEO

Jack Phillips

CEO Approval Rating

87/100

Read more